Namshik Han is the Head of Computational Biology group at the Milner Therapeutics Institute in University of Cambridge. He is leading the group and has responsibilities to develop and deliver the Milner’s computational biology and bioinformatics strategy. The main aim of the group is to develop and apply cutting-edge computational methods, such as artificial intelligence and machine learning, fulfilling the global mission of identifying new or better therapies from the analysis of biological data. The current projects within the group include (1) identification of new therapeutic targets in a variety of diseases, (2) stratification of patients to improve personalised medicine, (3) prediction of efficacy and safety of new and existing drugs and (4) identification of drug (re)positioning opportunities.
He read in both Law and Computer Science for Undergraduate and moved into Computational Biology for his Masters degree. After that, he spent 3 years to participate in a software system development project in Samsung Electronics. He then did his PhD projects in computational biology and machine learning (School of Computer Science, University of Manchester, 2007-2010). He started his postdoctoral works in computational cancer genomics (Faculty of Life Sciences, University of Manchester, 2010) and then in computational cancer epigenomics (Gurdon Institute, University of Cambridge, 2013).
